HomeNANO • EPA
add
Nanobiotix SA
Previous close
€23.75
Day range
€21.60 - €23.40
Year range
€2.62 - €25.50
Market cap
1.19B EUR
Avg Volume
643.25K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 13.32M | 186.77% |
Operating expense | 12.91M | -21.29% |
Net income | -2.69M | 75.39% |
Net profit margin | -20.21 | 91.42% |
Earnings per share | — | — |
EBITDA | 545.50K | 104.80% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.82M | -56.56% |
Total assets | 45.17M | -47.88% |
Total liabilities | 114.13M | 5.23% |
Total equity | -68.95M | — |
Shares outstanding | 48.21M | — |
Price to book | -16.61 | — |
Return on assets | 2.25% | — |
Return on capital | -5.75% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.69M | 75.39% |
Cash from operations | -8.71M | -198.34% |
Cash from investing | -81.00K | 67.60% |
Cash from financing | -1.42M | -6.59% |
Net change in cash | -10.46M | -133.78% |
Free cash flow | 330.25K | 104.44% |
About
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
CEO
Founded
2003
Website
Employees
103
